FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113874736> ?p ?o ?g. }

• W2113874736 endingPage "179" @default.
• W2113874736 startingPage "173" @default.
• W2113874736 abstract "Cyclo-oxygenase (COX)-2-selective non-steroidal anti-inflammatory drugs (NSAIDs) and non-selective NSAIDs plus a proton-pump inhibitor (PPI) have similar upper gastrointestinal outcomes, but risk of clinical outcomes across the entire gastrointestinal tract might be lower with selective drugs than with non-selective drugs. We aimed to compare risk of gastrointestinal events associated with celecoxib versus diclofenac slow release plus omeprazole.We undertook a 6-month, double-blind, randomised trial in patients with osteoarthritis or rheumatoid arthritis at increased gastrointestinal risk at 196 centres in 32 countries or territories. Patients tested negative for Helicobacter pylori and were aged 60 years and older or 18 years and older with previous gastroduodenal ulceration. We used a computer-generated randomisation schedule to assign patients in a 1:1 ratio to receive celecoxib 200 mg twice a day or diclofenac slow release 75 mg twice a day plus omeprazole 20 mg once a day. Patients and investigators were masked to treatment allocation. The primary endpoint was a composite of clinically significant upper or lower gastrointestinal events adjudicated by an independent committee. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00141102.4484 patients were randomly allocated to treatment (2238 celecoxib; 2246 diclofenac plus omeprazole) and were included in intention-to-treat analyses. 20 (0.9%) patients receiving celecoxib and 81 (3.8%) receiving diclofenac plus omeprazole met criteria for the primary endpoint (hazard ratio 4.3, 95% CI 2.6-7.0; p<0.0001). 114 (6%) patients taking celecoxib versus 167 (8%) taking diclofenac plus omeprazole withdrew early because of gastrointestinal adverse events (p=0.0006).Risk of clinical outcomes throughout the gastrointestinal tract was lower in patients treated with a COX-2-selective NSAID than in those receiving a non-selective NSAID plus a PPI. These findings should encourage review of approaches to reduce risk of NSAID treatment.Pfizer Inc." @default.
• W2113874736 created "2016-06-24" @default.
• W2113874736 creator A5005906845 @default.
• W2113874736 creator A5014688560 @default.
• W2113874736 creator A5035336989 @default.
• W2113874736 creator A5079437075 @default.
• W2113874736 creator A5085313387 @default.
• W2113874736 creator A5091853765 @default.
• W2113874736 date "2010-07-01" @default.
• W2113874736 modified "2023-10-10" @default.
• W2113874736 title "Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial" @default.
• W2113874736 cites W1517208287 @default.
• W2113874736 cites W1569709067 @default.
• W2113874736 cites W1625506357 @default.
• W2113874736 cites W1967858966 @default.
• W2113874736 cites W1969798546 @default.
• W2113874736 cites W2022630327 @default.
• W2113874736 cites W2024835957 @default.
• W2113874736 cites W2026298929 @default.
• W2113874736 cites W2034013987 @default.
• W2113874736 cites W2046110434 @default.
• W2113874736 cites W2054305086 @default.
• W2113874736 cites W2107510055 @default.
• W2113874736 cites W2113079259 @default.
• W2113874736 cites W2113737049 @default.
• W2113874736 cites W2118007883 @default.
• W2113874736 cites W2122355853 @default.
• W2113874736 cites W2128541151 @default.
• W2113874736 cites W2133278537 @default.
• W2113874736 cites W2138550164 @default.
• W2113874736 cites W2139295271 @default.
• W2113874736 cites W2152348310 @default.
• W2113874736 cites W2161521043 @default.
• W2113874736 cites W2163756514 @default.
• W2113874736 cites W2167792025 @default.
• W2113874736 cites W2169330249 @default.
• W2113874736 cites W2170108033 @default.
• W2113874736 cites W2330496155 @default.
• W2113874736 cites W2331085743 @default.
• W2113874736 cites W4239471829 @default.
• W2113874736 doi "https://doi.org/10.1016/s0140-6736(10)60673-3" @default.
• W2113874736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20638563" @default.
• W2113874736 hasPublicationYear "2010" @default.
• W2113874736 type Work @default.
• W2113874736 sameAs 2113874736 @default.
• W2113874736 citedByCount "314" @default.
• W2113874736 countsByYear W21138747362012 @default.
• W2113874736 countsByYear W21138747362013 @default.
• W2113874736 countsByYear W21138747362014 @default.
• W2113874736 countsByYear W21138747362015 @default.
• W2113874736 countsByYear W21138747362016 @default.
• W2113874736 countsByYear W21138747362017 @default.
• W2113874736 countsByYear W21138747362018 @default.
• W2113874736 countsByYear W21138747362019 @default.
• W2113874736 countsByYear W21138747362020 @default.
• W2113874736 countsByYear W21138747362021 @default.
• W2113874736 countsByYear W21138747362022 @default.
• W2113874736 countsByYear W21138747362023 @default.
• W2113874736 crossrefType "journal-article" @default.
• W2113874736 hasAuthorship W2113874736A5005906845 @default.
• W2113874736 hasAuthorship W2113874736A5014688560 @default.
• W2113874736 hasAuthorship W2113874736A5035336989 @default.
• W2113874736 hasAuthorship W2113874736A5079437075 @default.
• W2113874736 hasAuthorship W2113874736A5085313387 @default.
• W2113874736 hasAuthorship W2113874736A5091853765 @default.
• W2113874736 hasConcept C126322002 @default.
• W2113874736 hasConcept C142724271 @default.
• W2113874736 hasConcept C203092338 @default.
• W2113874736 hasConcept C204787440 @default.
• W2113874736 hasConcept C207103383 @default.
• W2113874736 hasConcept C2776164576 @default.
• W2113874736 hasConcept C2776467144 @default.
• W2113874736 hasConcept C2777077863 @default.
• W2113874736 hasConcept C2777498785 @default.
• W2113874736 hasConcept C2777575956 @default.
• W2113874736 hasConcept C2779826273 @default.
• W2113874736 hasConcept C2781025758 @default.
• W2113874736 hasConcept C44249647 @default.
• W2113874736 hasConcept C535046627 @default.
• W2113874736 hasConcept C71924100 @default.
• W2113874736 hasConcept C90924648 @default.
• W2113874736 hasConcept C98274493 @default.
• W2113874736 hasConceptScore W2113874736C126322002 @default.
• W2113874736 hasConceptScore W2113874736C142724271 @default.
• W2113874736 hasConceptScore W2113874736C203092338 @default.
• W2113874736 hasConceptScore W2113874736C204787440 @default.
• W2113874736 hasConceptScore W2113874736C207103383 @default.
• W2113874736 hasConceptScore W2113874736C2776164576 @default.
• W2113874736 hasConceptScore W2113874736C2776467144 @default.
• W2113874736 hasConceptScore W2113874736C2777077863 @default.
• W2113874736 hasConceptScore W2113874736C2777498785 @default.
• W2113874736 hasConceptScore W2113874736C2777575956 @default.
• W2113874736 hasConceptScore W2113874736C2779826273 @default.
• W2113874736 hasConceptScore W2113874736C2781025758 @default.
• W2113874736 hasConceptScore W2113874736C44249647 @default.
• W2113874736 hasConceptScore W2113874736C535046627 @default.
• W2113874736 hasConceptScore W2113874736C71924100 @default.
• W2113874736 hasConceptScore W2113874736C90924648 @default.

• next